Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 291

1.

Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plésiat P.

Antimicrob Agents Chemother. 2004 May;48(5):1797-802.

PMID:
15105137
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Two efflux systems expressed simultaneously in clinical Pseudomonas aeruginosa].

Hocquet D, Llanes C, Patry I, El Garch F, Plésiat P.

Pathol Biol (Paris). 2004 Oct;52(8):455-61. French.

PMID:
15465264
[PubMed - indexed for MEDLINE]
3.
4.

[The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].

Yi MY, Wang PY, Huang HJ, Liu YC.

Zhonghua Yi Xue Za Zhi. 2006 Feb 21;86(7):457-62. Chinese.

PMID:
16677571
[PubMed - indexed for MEDLINE]
5.

Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa.

Sobel ML, Hocquet D, Cao L, Plesiat P, Poole K.

Antimicrob Agents Chemother. 2005 May;49(5):1782-6.

PMID:
15855496
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pentachlorophenol induction of the Pseudomonas aeruginosa mexAB-oprM efflux operon: involvement of repressors NalC and MexR and the antirepressor ArmR.

Starr LM, Fruci M, Poole K.

PLoS One. 2012;7(2):e32684. doi: 10.1371/journal.pone.0032684. Epub 2012 Feb 29.

PMID:
22393435
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary clinical isolates of Pseudomonas aeruginosa.

Beinlich KL, Chuanchuen R, Schweizer HP.

FEMS Microbiol Lett. 2001 May 1;198(2):129-34.

PMID:
11430403
[PubMed - indexed for MEDLINE]
8.

A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa.

Mesaros N, Glupczynski Y, Avrain L, Caceres NE, Tulkens PM, Van Bambeke F.

J Antimicrob Chemother. 2007 Mar;59(3):378-86. Epub 2007 Feb 8.

PMID:
17289770
[PubMed - indexed for MEDLINE]
Free Article
9.

nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome.

Saito K, Yoneyama H, Nakae T.

FEMS Microbiol Lett. 1999 Oct 1;179(1):67-72.

PMID:
10481088
[PubMed - indexed for MEDLINE]
10.

Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

Dean CR, Visalli MA, Projan SJ, Sum PE, Bradford PA.

Antimicrob Agents Chemother. 2003 Mar;47(3):972-8.

PMID:
12604529
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.

Hocquet D, Bertrand X, Köhler T, Talon D, Plésiat P.

Antimicrob Agents Chemother. 2003 Jun;47(6):1887-94.

PMID:
12760863
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.

Hocquet D, Roussel-Delvallez M, Cavallo JD, Plésiat P.

Antimicrob Agents Chemother. 2007 Apr;51(4):1582-3. Epub 2007 Jan 12. No abstract available.

PMID:
17220417
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation.

Nakajima A, Sugimoto Y, Yoneyama H, Nakae T.

Microbiol Immunol. 2002;46(6):391-5.

PMID:
12153116
[PubMed - indexed for MEDLINE]
15.

Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.

Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T.

Antimicrob Agents Chemother. 2000 Sep;44(9):2242-6.

PMID:
10952562
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.

Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T.

Antimicrob Agents Chemother. 2000 Dec;44(12):3322-7.

PMID:
11083635
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.

Wolter DJ, Black JA, Lister PD, Hanson ND.

J Antimicrob Chemother. 2009 Aug;64(2):294-300. doi: 10.1093/jac/dkp185. Epub 2009 May 25.

PMID:
19468029
[PubMed - indexed for MEDLINE]
Free Article
18.

Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.

Kiser TH, Obritsch MD, Jung R, MacLaren R, Fish DN.

Pharmacotherapy. 2010 Jul;30(7):632-8. doi: 10.1592/phco.30.7.632.

PMID:
20575627
[PubMed - indexed for MEDLINE]
19.

Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.

El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B.

APMIS. 2005 Mar;113(3):187-96.

PMID:
15799762
[PubMed - indexed for MEDLINE]
20.

Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.

Hocquet D, Nordmann P, El Garch F, Cabanne L, Plésiat P.

Antimicrob Agents Chemother. 2006 Apr;50(4):1347-51.

PMID:
16569851
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk